Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kaoru Kubota"'
Autor:
Masahiro Seike, Kakeru Hisakane, Shinji Nakamichi, Kaoru Kubota, Masaru Matsumoto, Rintaro Noro, Shinobu Kunugi, Kuniko Matsuda, Akihiko Miyanaga, Teppei Sugano, Yuji Minegishi, Akihiko Gemma
Publikováno v:
Anticancer Research. 41:2501-2509
Background/aim Pulmonary pleomorphic carcinoma (PPC) is a rare and aggressive tumor that is resistant to treatment. The expression and prognostic value of programmed cell death-ligand 1 (PD-L1) and its association with epithelial-mesenchymal transiti
Autor:
Rintaro Noro, Kuniko Matsuda, Masahiro Seike, Susumu Takeuchi, Koji Nakayama, Kaoru Kubota, Akihiko Gemma, Shinobu Kunugi
Publikováno v:
Anticancer research. 39(2)
Background/aim Malignant mesothelioma (MM) is an aggressive tumor with poor prognosis. The establishment of a new diagnostic and therapeutic approach for MM is expected. This study investigated the diagnostic significance of tenascin XB (TNXB) for MM
Autor:
Rintaro Noro, Shinobu Kunugi, Mika Chiba, Masahiro Seike, Kaoru Kubota, Akihiko Gemma, Arimi Ishikawa, Fenfei Zou, Kenichi Kobayashi
Publikováno v:
Anticancer Research. 38
BACKGROUND/AIM Recent clinical trials have shown that immune checkpoint blockades that target either PD-1 or PD-L1 yield remarkable responses in a subgroup of patients with non-small cell lung cancer (NSCLC). MATERIALS AND METHODS We retrospectively
Autor:
Kuniko Matsuda, Kaoru Kubota, Mika Chiba, Masahiro Seike, Akihiko Gemma, Akiko Takahashi, Akihiko Miyanaga, Susumu Takeuchi, Yuji Minegishi, Kenichi Kobayashi, Shinji Nakamichi
Publikováno v:
Anticancer research. 37(6)
Background/aim We evaluated the usefulness of reverse transcription-polymerase chain reaction (RT-PCR) for detecting anaplastic lymphoma kinase (ALK) translocations using cytology samples from lung cancer patients. Materials and methods We analyzed A
Autor:
Masaaki, Kawahara, Shinji, Atagi, Kiyoshi, Komuta, Hiroshige, Yoshioka, Masayuki, Kawasaki, Yuka, Fujita, Toshiro, Yonei, Fumitaka, Ogushi, Kaoru, Kubota, Naoyuki, Nogami, Michiko, Tsuchiya, Kazuhiko, Shibata, Yoshio, Tomizawa, Koichi, Minato, Kazuya, Fukuoka, Kazuhiro, Asami, Takeharu, Yamanaka
Publikováno v:
Anticancer research. 33(10)
Assessment of the efficacy of docetaxel plus carboplatin vs. paclitaxel plus carboplatin in Japanese patients with advanced non-small cell lung cancer (NSCLC).Chemotherapy-naïve patients were randomly assigned at a ratio of 2 to 1 to receive six cyc
Publikováno v:
Anticancer research. 32(9)
This study evaluated the safety and efficacy of combined zoledronic acid, cisplatin and docetaxel in patients with non-small cell lung cancer (NSCLC) with bone metastases.Cisplatin 80 mg/m(2) and docetaxel 60 mg/m(2) with zoledronic acid 4 mg were gi
Autor:
Nobuyuki, Yamamoto, Takeharu, Yamanaka, Yukito, Ichinose, Kaoru, Kubota, Hiroshi, Sakai, Akihiko, Gemma, Nagahiro, Saijo, Masahiro, Fukuoka, Hisanobu, Niitani
Publikováno v:
Anticancer research. 30(7)
The antimetabolic agent S-1 inhibits thymidylate synthase similar to pemetrexed, but through a different mechanism of action. Whether the antitumour activity of S-1 depends on histological type remains unclear. We analysed pooled data from 2 phase II